General
Preferred name
HISTAMINE
Synonyms
HISTAMINE DIHYDROCHLORIDE ()
Ergamine ()
peremin ()
Ceplene ()
Histamine 2HCl ()
Ergotidine ()
Histamine Phosphate ()
Histamine (phosphate) ()
Histamine (dihydrochloride) ()
Histamine diphosphate ()
NSC-257873 ()
Histamine hydrochloride ()
Histaminum hydrochloricum ()
Histamine dihydrocloride ()
[3H]histamine ()
NSC-33792 ()
.beta.-aminoethylglyoxaline ()
P&D ID
PD012019
CAS
51-45-6
56-92-8
6890-40-0
117932-92-0
51-74-1
Tags
natural product
drug
available
Approved by
FDA
First approval
1939
Drug Status
investigational
approved
withdrawn
Drug indication
Diagnostic imaging
Respiratory allergy
Stimulant (gastric secretory)
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Histamine is a potent pro-inflammatory mediator that is principally released from mast cells. It is also involved in regulating physiological function in the gut, and acts as a neurotransmitter.
Histamine activates carbonic anhydrases, and is most potent at the CA5A and CA1 isoforms (KA values 10 and 2100 nM respectively) . (GtoPdb)
DESCRIPTION Endogenous agonist at dopamine D1-5 receptors (Tocris Bioactive Compound Library)
DESCRIPTION Endogenous histamine receptor agonist (Tocriscreen Plus)
DESCRIPTION Endogenous neurotransmitter (LOPAC library)
DESCRIPTION Endogenous histamine receptor agonist (Tocriscreen Total)
DESCRIPTION Histamine dihydrochloride is a histamine salt used to prevent relapse in patients with acute myeloid leukemia (AML). It is also used as an active ingredient in topical analgesia for temporary relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, bruises, sprains and strains. (BOC Sciences Bioactive Compounds)
DESCRIPTION Histamine phosphate is a potent histamine receptor agonist and vasodilator. It acts directly on the blood vessels to dilate arteries and capillaries mediated by both H1- and H2-receptors. (BOC Sciences Bioactive Compounds)
Cell lines
0
Organisms
3
Compound Sets
36
Cayman Chemical Bioactives
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP Approved Drugs
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
Ki Database
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Other bioactive compounds
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Plus
Tocriscreen Total
Withdrawn 2.0
ZINC Tool Compounds
External IDs
103
Properties
(calculated by RDKit )
Molecular Weight
111.08
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
-0.09
TPSA
54.7
Fraction CSP3
0.4
Chiral centers
0.0
Largest ring
5.0
QED
0.56
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
7-TM Receptors
Pathway
GPCR/G protein
Neuroscience
Immunology/Inflammation
Metabolic Enzyme/Protease
Neuronal Signaling
Target
HT
H1 receptor
H2 receptor
HRH1, HRH2, HRH3, HRH4
Endogenous Metabolite
Histamine Receptor
Primary Target
Histamine H1 Receptors
MOA
Agonist
NADPH Oxidase Inhibitors
Histamine Receptor Agonists
"NADPH Oxidase Inhibitors
Histamine Receptor Agonists"
Histamine Receptor agonist
Member status
member
Indication
allergic rhinitis
ATC
V
Therapeutic Class
Antiallergic Agents
Diagnostic Agents
Solubility
Soluble in Methanol (Slightly, Heated), Water (Sparingly)
Soluble in Aqueous Acid (Slightly), Water (Slightly)
Source data